Polaris Partners
Polaris Partners led the Series B round.
The company's diabetic foot ulcer detection platform is now available through 40 VA medical centers.
The round now comes to a total of $16.55 million, and will continue to support the company's push into the VA and commercial payer markets.
The new funding was led by Icon Ventures with participation from Polaris Partners, RRE Ventures, .406 Ventures and Silicon Valley Bank.
The integrated behavioral and primary care platform said that it will be focusing its upcoming efforts on serving the Medicaid population.